Home Drug Codes J Codes J7042 · DEXTROSE 5%-0.9% NACL
Updated July 1st, 2026

DEXTROSE 5%-0.9% NACL J Code: J7042

5% dextrose/normal saline (500 ml = 1 unit)

Login to unlock all benchmarks

Q4 2026 Medicare Payment Limit for J7042, effective October 1, 2026: $1.265 per HCPCS billing unit, up 4.1% from $1.215. From CMS's final file.

?
Medicare Payment Limit ?
$1.215
/ HCPCS billing unit · Q3 2026
APC Payment Limit ?
Not published
CMS publishes none for Q3 2026
ASP ?
$•••.••
Login to view
WAC · AWP ?
$•••.••
Login to view
NDCs Crosswalked ?
4
View NDC crosswalk →

Drug & Product Overview

HCPCS Descriptor 5% dextrose/normal saline (500 ml = 1 unit)
HCPCS Added Date January 1, 1984
Manufacturer Multiple Manufacturers
Route of Administration Intravenous
Generic Status Multi-Source; Generic
Dosage Form Injection, Solution

About DEXTROSE 5%-0.9% NACL

Dextrose 5%-0.9% NACL is a medication aligned to the HCPCS J Code: J7042 for billing, pricing, and reimbursement purposes in the United States. It is a Misc. drug administered via the intravenous route and manufactured by multiple companies.

According to CMS Drug Use Information: Drug uses not available

Disclaimer: This is a summary and does not contain all possible information about this product. For complete information about this product or your specific health needs, ask your healthcare professional.

NDC Code Information

Based on publicly available CMS files. The list of NDCs below is not exhaustive.

NDC Code Drug Manufacturer Billing Units / Pkg Package Size
00990-7941-03 Dextrose and Sodium Chloride ICU Medical Inc. 24 Dextrose and Sodium Ch loride Intraveno… Login for More
00990-7941-09 Dextrose and Sodium Chloride ICU Medical Inc. 24 Dextrose and Sodium Ch loride Intraveno… Login for More
63323-0870-10 Dextrose and Sodium Chloride Fresenius Kabi USA, LLC 20 Dextrose and Sodium Ch loride Intraveno… Login for More
63323-0870-74 Dextrose and Sodium Chloride Fresenius Kabi USA, LLC 20 Dextrose and Sodium Ch loride Intraveno… Login for More
Login for the full NDC crosswalk View pricing, complete NDC-to-HCPCS alignments, and package details.
Login →

DEXTROSE 5%-0.9% NACL Pricing & Reimbursement

J7042 Private Payer Reimbursement
$1.26 / HCPCS unit as of Jan 2026

National median reimbursement across major commercial payers.

Create an account on PayerPrice for more information →
UnitedHealthcare, BlueCross BlueShield, Aetna, Cigna

Historical Graphing and Billing Calculator

per HCPCS unit
As of Q3 2026

DEXTROSE 5%-0.9% NACL CPT Administration Codes

The below list of CPT codes is intended for informational purposes only and may not be exhaustive. CPT® codes and descriptions are copyright American Medical Association (AMA). All rights reserved.

CPT Code Description
96360 Intravenous infusion, hydration; initial, 31 minutes to 1 hour
96361 Intravenous infusion, hydration; each additional hour (List separately in addition to code for primary procedure)
Not on the CMS JW / JZ list

CMS does not include Dextrose 5%-0.9% NACL (J7042) on its list of HCPCS pertaining to single-dose containers. Per CMS guidelines, the JZ/JW wastage modifiers may not apply when billing J7042. Wastage billing guide →

DEXTROSE 5%-0.9% NACL Medically Unlikely Edits (MUE)

The most billing units of J7042 Medicare will pay for one patient in one day, as published by CMS. 1 unit = 500 ml. The limit is different in the office and the hospital. Use the one for your setting.

Practitioner Office
6 units / day
= 3,000 ml per day
Hospital Outpatient
12 units / day
= 6,000 ml per day

MAI 3 · Date of Service Edit: Clinical. Per-day limit based on clinical expectations; excess units are denied but may be appealed with documentation of medical necessity. See all MUE limits →

ml Enter a dose to see how many billing units it is and whether it is under the limit.

DEXTROSE 5%-0.9% NACL Clinical Information

Indications and drug classification.

Treated Diseases & Conditions

This list of indications is not exhaustive and may be subject to errors. The information on BuyandBill.com is intended for informational purposes only and should not be used for medical advice.

parenteral replenishment of fluid, minimal carbohydrate calories, and sodium chloride
Drug Class
Increased Large Intestinal Motility [PE]Inhibition Large Intestine Fluid/Electrolyte Absorption [PE]Osmotic Activity [MoA]Osmotic Laxative [EPC]

Login for BuyandBill.com Analytics

Unlock deeper insights with BuyandBill’s Comparative Report!

  • Compare ASP, WAC, and AWP across drugs.
  • Visualize Drug Price Movement Over Time
  • Tailor reports to drug class, manufacturer, or HCPCS Code.
  • Compare Biosimilar and 505(b)(2) products.

Frequently Asked Questions

Is there an available Dextrose 5%-0.9% Nacl billing and coding guide?
We have not yet identified a manufacturer source of Dextrose 5%-0.9% Nacl billing and coding information.
Are there any available Dextrose 5%-0.9% Nacl patient assistance programs?
Our team did not identify a source for Dextrose 5%-0.9% Nacl patient assistance information. Please reach out to our team if you feel that this is a mistake.
Where can I find Dextrose 5%-0.9% Nacl prescribing information?
Our team is still working to identify a prescribing information source for DEXTROSE 5%-0.9% NACL
Where can I find Dextrose 5%-0.9% Nacl side effect information?
Our team has not yet identified a source of side effects information for DEXTROSE 5%-0.9% NACL. Please check back in a few weeks.
Does billing DEXTROSE 5%-0.9% NACL require JZ/JW wastage modifiers?
CMS does not include DEXTROSE 5%-0.9% NACL (J7042) on its list of HCPCS pertaining to single-dose containers. Per CMS guidelines, the JZ/JW wastage modifiers may not apply when billing J7042. For more information, visit the link below.

About BuyandBill.com:

The BuyandBill.com team is dedicated to delivering high-quality coding and billing information for office-administered drugs. We continuously research HCPCS-coded medications to expand our resources and ensure data accuracy. Manufacturers: click here to sponsor your medication, and we will ensure the most accurate and detailed information is displayed.